MannKind expands United Therapeutics partnership for second inhaled therapy
Go back to MannKind expands United Therapeutics partnership for second inhaled therapy| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 4.15 -0.11 (2.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.26 | 52 Week High | $2.51 | |||
| Open | $4.28 | 52 Week Low | $0.41 | |||
| Day High | $4.36 | P/E | N/A | |||
| Day Low | $4.11 | EPS | $-0.64 | |||
| Volume | 3,204,974 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 513.12 -7.88 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $521.00 | 52 Week High | $164.04 | |||
| Open | $523.23 | 52 Week Low | $97.52 | |||
| Day High | $528.02 | P/E | 93.81 | |||
| Day Low | $512.29 | EPS | $5.47 | |||
| Volume | 415,574 | |||||
